• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

锥体外系症状评定量表(ESRS)手册。

Manual for the Extrapyramidal Symptom Rating Scale (ESRS).

作者信息

Chouinard Guy, Margolese Howard C

机构信息

Clinical Psychopharmacology Unit, Allan Memorial Institute, McGill University Health Centre, and Department of Psychiatry, McGill University, Montreal, QC, Canada, H3A 1A1.

出版信息

Schizophr Res. 2005 Jul 15;76(2-3):247-65. doi: 10.1016/j.schres.2005.02.013. Epub 2005 Apr 18.

DOI:10.1016/j.schres.2005.02.013
PMID:15949657
Abstract

The Extrapyramidal Symptom Rating Scale (ESRS) was developed to assess four types of drug-induced movement disorders (DIMD): Parkinsonism, akathisia, dystonia, and tardive dyskinesia (TD). Comprehensive ESRS definitions and basic instructions are given. Factor analysis provided six ESRS factors: 1) hypokinetic Parkinsonism; 2) orofacial dyskinesia; 3) trunk/limb dyskinesia; 4) akathisia; 5) tremor; and 6) tardive dystonia. Two pivotal studies found high inter-rater reliability correlations in both antipsychotic-induced movement disorders and idiopathic Parkinson disease. For inter-rater reliability and certification of raters, >or=80% of item ratings of the complete scale should be +/-1 point of expert ratings and >or=70% of ratings on individual items of each ESRS subscale should be +/-1 point of expert ratings. During a cross-scale comparison, AIMS and ESRS were found to have a 96% (359/374) agreement between TD-defined cases by DSM-IV TD criteria. Two recent international studies using the ESRS included over 3000 patients worldwide and showed an incidence of TD ranging from 10.2% (2000) to 12% (1998). ESRS specificity was investigated through two different approaches, path analyses and ANCOVA PANSS factors changes, which found that ESRS measurement of drug-induced EPS is valid and discriminative from psychiatric symptoms.

摘要

锥体外系症状评定量表(ESRS)旨在评估四种药物诱发的运动障碍(DIMD):帕金森症、静坐不能、肌张力障碍和迟发性运动障碍(TD)。文中给出了ESRS的全面定义和基本说明。因子分析得出了六个ESRS因子:1)运动减少型帕金森症;2)口面部运动障碍;3)躯干/肢体运动障碍;4)静坐不能;5)震颤;6)迟发性肌张力障碍。两项关键研究发现,在抗精神病药物诱发的运动障碍和特发性帕金森病中,评分者间的可靠性相关性都很高。为确保评分者间的可靠性和评分者的资质认证,完整量表中>或=80%的项目评分应与专家评分相差±1分,每个ESRS子量表中单个项目>或=70%的评分应与专家评分相差±1分。在跨量表比较中,根据DSM-IV TD标准,发现AIMS和ESRS在TD定义病例上的一致性为96%(359/374)。最近两项使用ESRS的国际研究涵盖了全球3000多名患者,结果显示TD的发病率在10.2%(2000年)至12%(1998年)之间。通过两种不同方法(路径分析和协方差分析PANSS因子变化)对ESRS的特异性进行了研究,结果发现ESRS对药物诱发的锥体外系反应的测量是有效的,且能与精神症状相区分。

相似文献

1
Manual for the Extrapyramidal Symptom Rating Scale (ESRS).锥体外系症状评定量表(ESRS)手册。
Schizophr Res. 2005 Jul 15;76(2-3):247-65. doi: 10.1016/j.schres.2005.02.013. Epub 2005 Apr 18.
2
The Extrapyramidal Symptom Rating Scale and Its Abbreviated Version: A Critical Review of Clinimetric Properties.锥体外系症状评定量表及其简表:计量学特性的批判性评价。
Psychother Psychosom. 2023;92(6):359-366. doi: 10.1159/000535113. Epub 2023 Dec 7.
3
Abnormal Involuntary Movement Scale (AIMS) and Extrapyramidal Symptom Rating Scale (ESRS): cross-scale comparison in assessing tardive dyskinesia.异常不自主运动量表(AIMS)与锥体外系症状评定量表(ESRS):评估迟发性运动障碍的跨量表比较
Schizophr Res. 2005 Sep 15;77(2-3):119-28. doi: 10.1016/j.schres.2005.03.008.
4
A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.锂盐治疗的情感障碍患者中帕金森综合征和迟发性运动障碍的横断面研究。
J Clin Psychiatry. 1996 Jan;57(1):22-8.
5
The inter-relationships of tardive dyskinesia, parkinsonism, akathisia and tardive dystonia: the Curaçao Extrapyramidal Syndromes Study II.迟发性运动障碍、帕金森症、静坐不能和迟发性肌张力障碍的相互关系:库拉索锥体外系综合征研究II
Schizophr Res. 1997 Aug 29;26(2-3):235-42. doi: 10.1016/s0920-9964(97)00058-3.
6
Clozapine-induced tardive dyskinesia in schizophrenic patients taking clozapine as a first-line antipsychotic drug.氯氮平致精神分裂症患者服用氯氮平作为一线抗精神病药物后迟发性运动障碍。
World J Biol Psychiatry. 2009;10(4 Pt 3):919-24. doi: 10.1080/15622970802481895.
7
Assessment of extrapyramidal symptoms during acute neuroleptic treatment.急性抗精神病药物治疗期间锥体外系症状的评估。
J Clin Psychiatry. 1995 Mar;56(3):94-100.
8
A qualitative assessment of the neurological safety of antipsychotic drugs; an analysis of a risperidone database.抗精神病药物神经安全性的定性评估;利培酮数据库分析
Pharmacopsychiatry. 2001 May;34(3):104-10. doi: 10.1055/s-2001-14282.
9
Extrapyramidal syndromes in neuroleptic-treated patients: prevalence, risk factors, and association with tardive dyskinesia.接受抗精神病药物治疗患者的锥体外系综合征:患病率、危险因素及与迟发性运动障碍的关联
J Clin Psychopharmacol. 1999 Jun;19(3):203-8. doi: 10.1097/00004714-199906000-00002.
10
The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.甲氧氯普胺所致迟发性运动障碍和急性锥体外系运动障碍的患病率。
Arch Intern Med. 1993 Jun 28;153(12):1469-75.

引用本文的文献

1
Atypical antipsychotics for autism spectrum disorder: a network meta-analysis.用于自闭症谱系障碍的非典型抗精神病药物:一项网状荟萃分析。
Cochrane Database Syst Rev. 2025 May 21;5(5):CD014965. doi: 10.1002/14651858.CD014965.pub2.
2
Switching antipsychotics versus continued current treatment in people with non-responsive schizophrenia.对难治性精神分裂症患者换用抗精神病药物与继续当前治疗的比较
Cochrane Database Syst Rev. 2025 Apr 11;4(4):CD011885. doi: 10.1002/14651858.CD011885.pub2.
3
Longitudinal analysis of proinflammatory and anti-inflammatory cytokines in the cerebrospinal fluid and peripheral blood of treatment-naïve first-episode psychosis patients, and their correlation with psychosis severity and cognitive impairment in sub-Saharan Africa.
对撒哈拉以南非洲地区初发未治疗的首发精神病患者脑脊液和外周血中促炎和抗炎细胞因子的纵向分析,及其与精神病严重程度和认知障碍的相关性。
BMJ Open. 2025 Apr 2;15(4):e098347. doi: 10.1136/bmjopen-2024-098347.
4
Pentoxifylline adjunct to risperidone for negative symptoms of stable schizophrenia: a randomized, double-blind, placebo-controlled trial.己酮可可碱辅助利培酮治疗稳定型精神分裂症阴性症状:一项随机、双盲、安慰剂对照试验
Int J Neuropsychopharmacol. 2024 Dec 28;28(1). doi: 10.1093/ijnp/pyae051.
5
A Rare Occurrence of Delayed Olanzapine-Induced Oculogyric Crisis in a Postpartum Patient: A Case Report.产后患者中罕见的奥氮平所致迟发性动眼危象:一例报告
Cureus. 2024 Sep 24;16(9):e70127. doi: 10.7759/cureus.70127. eCollection 2024 Sep.
6
Prevalence of spontaneous movement disorders (dyskinesia, parkinsonism, akathisia and dystonia) in never-treated patients with chronic and first-episode psychosis: a systematic review and meta-analysis.从未接受治疗的慢性和首发精神病患者中自发性运动障碍(运动障碍、帕金森病、静坐不能和肌张力障碍)的患病率:系统评价和荟萃分析。
BMJ Ment Health. 2024 Sep 22;27(1):e301184. doi: 10.1136/bmjment-2024-301184.
7
Exploring the Relationships Between Antipsychotic Dosage and Voice Characteristics in Relation to Extrapyramidal Symptoms.探究抗精神病药物剂量与语音特征之间与锥体外系症状相关的关系。
Psychiatry Investig. 2024 Aug;21(8):822-831. doi: 10.30773/pi.2023.0417. Epub 2024 Aug 8.
8
Extrapyramidal side effects with nonantipsychotic medications.非抗精神病药物的锥体外系副作用。
Ment Health Clin. 2024 Aug 2;14(4):233-235. doi: 10.9740/mhc.2024.08.233. eCollection 2024 Aug.
9
A Novel PDE10A Inhibitor for Tourette Syndrome and Other Movement Disorders.一种用于治疗妥瑞氏综合征和其他运动障碍的新型 PDE10A 抑制剂。
Cells. 2024 Jul 22;13(14):1230. doi: 10.3390/cells13141230.
10
Clinical presentation of first episode psychosis in people with and without HIV in KwaZulu-Natal, South Africa.南非夸祖鲁 - 纳塔尔省感染和未感染艾滋病毒人群首次发作精神病的临床表现
Early Interv Psychiatry. 2025 Jan;19(1):e13561. doi: 10.1111/eip.13561. Epub 2024 May 27.